Adjusted Age-Adjusted Charlson Comorbidity Index Score as a Risk Measure of Perioperative Mortality before Cancer Surgery

被引:65
|
作者
Chang, Chun-Ming [1 ,6 ]
Yin, Wen-Yao [1 ,6 ]
Wei, Chang-Kao [1 ,6 ]
Wu, Chin-Chia [1 ,6 ]
Su, Yu-Chieh [4 ,5 ]
Yu, Chia-Hui [1 ]
Lee, Ching-Chih [2 ,3 ,7 ]
机构
[1] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Surg, Chiayi, Taiwan
[2] Kaohsiung Vet Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kaohsiung, Taiwan
[3] Natl Def Med Ctr, Sch Med, Taipei, Taiwan
[4] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Hematol Oncol, Dept Internal Med, Chiayi, Taiwan
[5] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Ctr Canc, Chiayi, Taiwan
[6] Tzu Chi Univ, Sch Med, Hualien, Taiwan
[7] Triserv Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan
来源
PLOS ONE | 2016年 / 11卷 / 02期
关键词
SHORT-TERM; PATIENT READMISSION; RADICAL CYSTECTOMY; OLDER-ADULTS; MORBIDITY; IMPACT; VALIDATION; OUTCOMES; PANCREATICODUODENECTOMY; PREDICTORS;
D O I
10.1371/journal.pone.0148076
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Identification of patients at risk of death from cancer surgery should aid in preoperative preparation. The purpose of this study is to assess and adjust the age-adjusted Charlson comorbidity index (ACCI) to identify cancer patients with increased risk of perioperative mortality. Methods We identified 156,151 patients undergoing surgery for one of the ten common cancers between 2007 and 2011 in the Taiwan National Health Insurance Research Database. Half of the patients were randomly selected, and a multivariate logistic regression analysis was used to develop an adjusted-ACCI score for estimating the risk of 90-day mortality by variables from the original ACCI. The score was validated. The association between the score and perioperative mortality was analyzed. Results The adjusted-ACCI score yield a better discrimination on mortality after cancer surgery than the original ACCI score, with c-statics of 0.75 versus 0.71. Over 80 years of age, 70-80 years, and renal disease had the strongest impact on mortality, hazard ratios 8.40, 3.63, and 3.09 (P < 0.001), respectively. The overall 90-day mortality rates in the entire cohort varied from 0.9%, 2.9%, 7.0%, and 13.2% in four risk groups stratifying by the adjusted-ACCI score; the adjusted hazard ratio for score 4-7, 8-11, and >= 12 was 2.84, 6.07, and 11.17 (P < 0.001), respectively, in 90-day mortality compared to score 0-3. Conclusions The adjusted-ACCI score helps to identify patients with a higher risk of 90-day mortality after cancer surgery. It might be particularly helpful for preoperative evaluation of patients over 80 years of age.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Adjusted Age-Adjusted Charlson Comorbidity Index Score as a Risk Measure of Perioperative Mortality before Cancer Surgery (vol 11, e0148076, 2016)
    Chang, Chun-Ming
    Yin, Wen-Yao
    Wei, Chang-Kao
    Wu, Chin-Chia
    Su, Yu-Chieh
    Yu, Chia-Hui
    Lee, Ching-Chih
    [J]. PLOS ONE, 2016, 11 (06):
  • [2] Age-adjusted Charlson comorbidity score is associated with the risk of empyema in patients with COPD
    Ho, Chung-Han
    Chen, Yi-Chen
    Chu, Chin-Chen
    Wang, Jhi-Joung
    Liao, Kuang-Ming
    [J]. MEDICINE, 2017, 96 (36)
  • [3] The age-adjusted Charlson comorbidity index in minimally invasive mitral valve surgery
    Minol, Jan-Philipp
    Dimitrova, Vanessa
    Petrov, Georgi
    Langner, Robert
    Boeken, Udo
    Rellecke, Philipp
    Aubin, Hug
    Kamiya, Hiroyuki
    Sixt, Stephan
    Huhn, Ragnar
    Sugimura, Yukiharu
    Albert, Alexander
    Lichtenberg, Artur
    Akhyari, Payam
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2019, 56 (06) : 1124 - 1130
  • [4] Age-Adjusted Charlson Comorbidity Index Predicts Survival in Endometrial Cancer Patients
    Di Donato, Violante
    D'Oria, Ottavia
    Giannini, Andrea
    Bogani, Giorgio
    Fischetti, Margherita
    Santangelo, Giusi
    Tomao, Federica
    Palaia, Innocenza
    Perniola, Giorgia
    Muzii, Ludovico
    Panici, Pierluigi Benedetti
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2022, 87 (3-4) : 191 - 199
  • [5] The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients
    Zhou, Shi
    Zhang, Xing-Hu
    Zhang, Yuan
    Gong, Ge
    Yang, Xiang
    Wan, Wen-Hui
    [J]. CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1683 - 1691
  • [6] Using the age-adjusted Charlson comorbidity index to predict outcomes in emergency general surgery
    St-Louis, Etienne
    Iqbal, Sameena
    Feldman, Liane S.
    Sudarshan, Monisha
    Deckelbaum, Dan L.
    Razek, Tarek S.
    Khwaja, Kosar
    [J]. JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2015, 78 (02): : 318 - 323
  • [7] Predictive value of the age-adjusted Charlson comorbidity index on perioperative complications and survival in patients undergoing surgery for advanced ovarian cancer
    Suidan, R. S.
    Leitao, M. M.
    Zivanovic, O.
    Gardner, G. J.
    Sonoda, Y.
    Levine, D. A.
    Jewell, E.
    Brown, C. L.
    Abu-Rustum, N. R.
    Chi, D. S.
    [J]. GYNECOLOGIC ONCOLOGY, 2015, 137 : 179 - 179
  • [8] The Prognostic Value of the Age-Adjusted Charlson Comorbidity Index Among the Elderly with Breast Cancer
    Wang, Zhe
    Zhong, Ying
    Zhou, Yidong
    Mao, Feng
    Zhang, Xiaohui
    Wang, Changjun
    Sun, Qiang
    [J]. CLINICAL INTERVENTIONS IN AGING, 2023, 18 : 1163 - 1174
  • [9] Association of Age-adjusted Charlson Comorbidity Index With Orbital Fungal Disease Outcomes
    Kupcha, Anna C.
    Simmons, Brittany A.
    Law, James J.
    Liu, Yuhan
    Chen, Qingxia
    Shriver, Erin M.
    Brown, Eric N.
    Mawn, Louise A.
    [J]. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2022, 38 (01): : 53 - 58
  • [10] The impact of age-adjusted charlson comorbidity index and age-adjusted prostate cancer specific comorbidity index in men underwent radical prostatectomy: A competing risk analysis of long-term survival data
    Kang, Dong Hyuk
    Cho, Kang Su
    Hong, Sung Joon
    Choi, Young Deuk
    Cho, Nam Hoon
    Rha, Koon Ho
    Ham, Won Sik
    Lee, Joo Yong
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 : 70 - 70